×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [58]
自动化研究所 [19]
兰州理工大学 [15]
中国医学科学院 北... [15]
化学研究所 [14]
西北高原生物研究所 [13]
更多...
内容类型
期刊论文 [258]
会议论文 [27]
学位论文 [25]
其他 [4]
专利 [2]
SCI/SSCI论文 [1]
更多...
发表日期
2022 [27]
2021 [25]
2020 [27]
2019 [15]
2018 [33]
2017 [15]
更多...
学科主题
环境科学::环境水质... [2]
Biochemist... [1]
Chemistry [1]
Energy & F... [1]
Engineerin... [1]
Environmen... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共317条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study
期刊论文
BMC CANCER, 2023, 卷号: 23
作者:
Cao, Fei
;
Shi, Changsheng
;
Zhang, Guofu
;
Luo, Jun
;
Zheng, Jiaping
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2023/11/10
Hepatocellular carcinoma
Atezolizumab
Bevacizumab
Overall survival
Progression-free survival
Formation Mechanism of Precursor Films at High Temperatures: A Review
期刊论文
Chinese Journal of Mechanical Engineering (English Edition), 2022, 卷号: 35, 期号: 1
作者:
Lin, Qiaoli
;
Liu, Lu
;
Zhu, Wenqi
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2022/04/21
Contact angle
Oxide films
Temperature
Diffusing band
Film formations
Formation mechanism
Halo
Highest temperature
Interfacial structures
Precursor films
Recent researches
Research focus
Wetting foot
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
期刊论文
CANCER MEDICINE, 2022
作者:
Hao, Yue
;
Lin, Gen
;
Xiang, Jing
;
Wang, Wenxian
;
Xu, Chunwei
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/12/23
efficacy
immune-related adverse events
immunotherapy
thymoma
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
期刊论文
FRONTIERS IN PUBLIC HEALTH, 2022, 卷号: 10
作者:
Shao, Guoliang
;
Wang, Jingwen
;
Zhou, Xiaoying
;
Sun, Guojun
;
Dong, Zuojun
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2022/12/23
DEB-TACE
cTACE
partition survival model
cost-effectiveness analysis
hepatocellular carcinoma
Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?
期刊论文
RADIATION ONCOLOGY, 2022, 卷号: 17
作者:
Lv, Xiaojuan
;
Rao, Huiting
;
Feng, Tao
;
Wu, Chufan
;
Lou, Hanmei
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2022/12/22
Radiotherapy
Dose escalation
Lymph node
Uterine cervical neoplasms
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
;
Lin, Gen
;
Guan, Yelan
;
Zhang, Yuxin
;
Xu, Chunwei
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer
期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:
Yan, Min
;
Yuan, Peng
;
Ouyang, Quchang
;
Cheng, Ying
;
Han, Guohui
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2022/12/23
breast cancer
chemotherapy
efficacy
lobaplatin
neoplasm metastasis
safety
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study
期刊论文
CANCERS, 2022, 卷号: 14
作者:
Xie, Mingying
;
Li, Na
;
Xu, Xiaoling
;
Xu, Yanjun
;
Li, Hui
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/22
liver metastasis
non-small cell lung cancer
PD-L1
PD-1
PD-L1 inhibitor
CD8+T cell
Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:
Wu, Y. -L.
;
Zhou, Q.
;
Chen, M.
;
Pan, Y.
;
Jian, O.
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/23
CCRT
sCRT
PD-L1 inhibitor
©版权所有 ©2017 CSpace - Powered by
CSpace